Mgenplus Co. Ltd. (032790) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.096x

Based on the latest financial reports, Mgenplus Co. Ltd. (032790) has a cash flow conversion efficiency ratio of -0.096x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.75 Billion ≈ $-1.87 Million USD) by net assets (₩28.72 Billion ≈ $19.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 032790 net asset quality index to measure how much of total assets are equity-financed.

Mgenplus Co. Ltd. - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Mgenplus Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 032790 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Mgenplus Co. Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mgenplus Co. Ltd. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Coats Group PLC LSE:COA	0.184x
Clime Investment Management Ltd AU:CIW	-0.055x
NORTHERN FREEGOLD F:8N6	-0.086x
Komputronik S.A. WAR:KOM	-0.008x
Scidev Ltd AU:SDV	-0.014x
Bright Scholar Education Holdings Ltd Class A NYSE:BEDU	-0.021x
Daedong Steel Co. Ltd KQ:048470	-0.105x
Memphasys Ltd AU:MEM	-0.306x

Annual Cash Flow Conversion Efficiency for Mgenplus Co. Ltd. (2007–2025)

The table below shows the annual cash flow conversion efficiency of Mgenplus Co. Ltd. from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Mgenplus Co. Ltd..

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩33.69 Billion ≈ $22.83 Million	₩-2.78 Billion ≈ $-1.89 Million	-0.083x	+38.99%
2024-12-31	₩44.12 Billion ≈ $29.90 Million	₩-5.98 Billion ≈ $-4.05 Million	-0.135x	-141.94%
2023-12-31	₩36.99 Billion ≈ $25.07 Million	₩-2.07 Billion ≈ $-1.40 Million	-0.056x	-308.67%
2022-12-31	₩46.48 Billion ≈ $31.50 Million	₩1.25 Billion ≈ $845.30K	0.027x	+119.77%
2018-12-31	₩18.38 Billion ≈ $12.46 Million	₩-2.49 Billion ≈ $-1.69 Million	-0.136x	+51.90%
2017-12-31	₩22.54 Billion ≈ $15.27 Million	₩-6.36 Billion ≈ $-4.31 Million	-0.282x	-90.52%
2016-12-31	₩11.48 Billion ≈ $7.78 Million	₩-1.70 Billion ≈ $-1.15 Million	-0.148x	+61.17%
2015-12-31	₩8.59 Billion ≈ $5.82 Million	₩-3.28 Billion ≈ $-2.22 Million	-0.381x	-415.25%
2014-12-31	₩10.14 Billion ≈ $6.87 Million	₩1.23 Billion ≈ $831.40K	0.121x	+37.31%
2013-12-31	₩14.12 Billion ≈ $9.57 Million	₩1.24 Billion ≈ $842.96K	0.088x	-78.91%
2008-12-31	₩17.78 Billion ≈ $12.05 Million	₩7.43 Billion ≈ $5.03 Million	0.418x	+873.55%
2007-12-31	₩17.38 Billion ≈ $11.78 Million	₩745.57 Million ≈ $505.26K	0.043x	--

About Mgenplus Co. Ltd.

KQ:032790 Korea Biotechnology

Market Cap

$17.49 Million

₩25.81 Billion KRW

Market Cap Rank

#25515 Global

#1880 in Korea

Share Price

₩1005.00

Change (1 day)

+25.16%

52-Week Range

₩800.00 - ₩1090.00

All Time High

₩1090.00